First case of hemicrania continua responsive to galcanezumab

[1]  Katrina L Devick,et al.  Real‐World Patient Experience With Erenumab for the Preventive Treatment of Migraine , 2020, Headache.

[2]  R. Conley,et al.  Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment , 2020, Cephalalgia : an international journal of headache.

[3]  R. Conley,et al.  Trial of Galcanezumab in Prevention of Episodic Cluster Headache. , 2019, The New England journal of medicine.

[4]  M. Leone,et al.  Anti-CGRP in cluster headache therapy , 2019, Neurological Sciences.

[5]  S. Tepper.  CGRP and headache: a brief review , 2019, Neurological Sciences.

[6]  M. S. Matharu,et al.  Hemicrania Continua , 2006, Cephalalgia : an international journal of headache.